Company Profile
Arcutis Biotherapeutics Stock Price, News & Analysis
- Ticker:
- ARQT
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Arcutis Biotherapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
26.27 USD (-1.46%)
Close
Last updated: June 23, 2026 at 00:00
3.29B USD
Market cap
Why the stock is moving
ARQT is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Arcutis Biotherapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Arcutis Biotherapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Arcutis Biotherapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Arcutis Biotherapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
Arcutis Management to Present at Goldman Sachs 47th Annual Global Healthcare Conference
Source: Arcutis Biotherapeutics
- 03
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Source: Arcutis Biotherapeutics
- 04
Arcutis Announces First Quarter 2026 Financial Results and Provides Business Update
Source: Arcutis Biotherapeutics
- 05
Arcutis Management to Present at TD Cowen’s 46th Annual Health Care Conference
Source: Arcutis Biotherapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Arcutis Biotherapeutics (ARQT)?
Arcutis Biotherapeutics (ARQT) most recently closed at 26.27 USD, a -1.46% move versus the previous session.
What is the market cap of Arcutis Biotherapeutics (ARQT)?
Arcutis Biotherapeutics currently has a market capitalization of 3.29B USD on BioPharmSignal.
What does Arcutis Biotherapeutics do?
Arcutis Biotherapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is ARQT stock listed?
Arcutis Biotherapeutics (ARQT) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Arcutis Biotherapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Arcutis?
Arcutis Biotherapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Arcutis Biotherapeutics targeting with Arcutis?
Arcutis Biotherapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Biotherapeutics?
Arcutis Biotherapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.